Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on March 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Blood Chemistry Analyzer 59th Medical Wing

Closed
PANDHA-25-P-0000Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
Federal
Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.
Solicitation # 36C26027Q0058
The Department of Veterans Affairs, through Network Contracting Office 20, is seeking a comprehensive histology staining workflow system for the Puget Sound Health Care System in Seattle, Washington. The required system must include two immunohistochemistry and two in-situ hybridization immunostainers, two special stainers, and an integrated specimen tracking system to ensure patient safety, maintain a chain of custody, and monitor productivity. The workflow components must be fully automated, communicate with one another, and maintain compatibility with Data Innovations middleware as well as VISTA, Cerner, and any future electronic health record systems acquired by the VA. The contract follows a Cost Per Reportable Result pricing model and spans a base year from February 1, 2027, to January 31, 2028, with four subsequent one-year option periods extending through January 31, 2032. Technical requirements specify that the immunostainers must perform 100% of tests listed in the provided specifications and support simultaneous IHC, ISH, and Direct Immunofluorescence staining. Equipment must support Code 39 and Code 128 barcodes, include a safe hazardous waste removal system, and be provided with an uninterruptible power supply capable of supporting a 15-minute controlled shutdown. The contractor is responsible for the delivery, installation, and removal of equipment at no additional charge and must guarantee a minimum equipment uptime of 98%. Performance and method validation must adhere to CLSI guidelines and College of American Pathologists standards. Additionally, the contractor must comply with strict federal and VA information security directives, including those regarding data confidentiality and media sanitization. Emergency supply orders must be fulfilled within 24 hours of a verbal request, providing enough consumables for one week of normal operation.
260-NETWORK Contract Office 20 (36C260)

POSTED

1 day ago

DEADLINE

in 24 days
NAICS: 325413
New
Federal
6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Solicitation # 36C26227Q0046
The Department of Veterans Affairs, Network Contracting Office 22, is conducting a sources sought notice for the procurement of FDA approved reagents, supplies, consumables, and quality control materials for Werfen Hemochron Signature Elite instruments. This requirement supports the Pathology and Laboratory Medicine Service at the Southern Arizona VA Health Care System in Tucson, Arizona. The contract structure includes a base year from January 1, 2027, to December 31, 2028, followed by four subsequent option years extending through December 31, 2032. The selected contractor must provide 24/7 technical and product support at no additional cost and ensure all items are fully compatible with existing instrumentation without requiring workflow changes or retraining. Key operational requirements include strict adherence to manufacturer specifications for packaging and temperature control during transport. All supplied materials must maintain a minimum shelf life of 90 days, and shipments must clearly list lot numbers and expiration dates. Standard orders are required to be delivered within four working days, while emergency deliveries for defective or temperature-compromised items must be completed within 24 hours of a verbal order. This procurement is conducted as a brand name or equal acquisition under FAR 52.211-6. Interested respondents must provide their business size status, SAM.gov identifiers, and evidence of compliance with the Buy American Act and the Non-Manufacturer Rule.
262-NETWORK Contract Office 22 (36C262)

POSTED

2 days ago

DEADLINE

in 13 days

General Info

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

DWG, TX, 78236, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeSAN ANTONIO, TX, 78230, USA
Office AddressSAN ANTONIO, TX, 78230, USA
Contacts

Full Description

Show more

This notice is to advise the public of the intent of Defense Health Agency HCD-S to award a sole source contract to the contractor identified below.


WERFEN USA LLC (Werfen)


180 HARTWELL RD


BEDFORD MA 01730-2443


Description of Requirement:


Defense Health Agency HCD-S has a requirement for two (2) Blood Chemistry Analyzers (lease).


Justification for Sole Source Procurement:


The nature of this acquisition is highly specialized. The combination of technical specifications, physical constraints, and interoperability requirements creates a unique need that can only be met by one vendor, Werfen , with their NEO Iris system. No other known system can meet all of the Government's minimum requirements as detailed below:



Proprietary & Integrated Test Menu: The Government requires a comprehensive and specific panel of tests to be performed on a single platform, including highly specialized Antibody Screen, ABO/Rh, Antibody Titration, Antibody identification, Syphilis, Cytomegalovirus, HIV/HBV/HCV by Nucleic acid testing, WNV, Babesia, Hepatitis B Surface Antigen (HBsAg),Hepatitis B core Antibody (HBcAb), Hepatitis C Antibody (HCV Ab), Human Immunodeficiency virus types 1 and 2 antibody (HIV ½ ab), Human T Lymphotrophic virus types 1 and 2 antibody (HTLV ½ Ab), Chagas. The machine must also be able to test plasma and whole blood.



Market research indicates that only the Werden NEO Iris system integrates this exact combination of assays, including the critical, FDA-approved NAT tests, onto a single automated platform. Other vendors offer these tests on separate platforms, which would require additional space, increased staffing, workflow inefficiencies, and present significant integration challenges with our Laboratory Information System (LIS). This single, integrated platform is essential to meet the high-throughput demands of the Basic Military Training mission.



Unique Physical and Infrastructure Requirements: The laboratory space at the 59th MDW has strict and unalterable infrastructure limitations. The required analyzer must operate without an onsite water source or a floor drainage system and must not exceed the physical dimensions of 86.6” W x 35.4” D x 73.2” H. The NEO Iris analyzer is specifically designed to operate with self-contained fluidics and waste management, eliminating the need for external plumbing. This design feature, combined with its specific physical footprint, makes it the only system capable of being installed and operated in the designated space without costly and mission-disrupting facility modifications.



Advanced Sample Integrity and Handling: The SOW mandates a system with a unique combination of sample handling capabilities critical for the pediatric and low-volume samples common in a military trainee population. This includes clot, bubble, and short sample detection, automatic reflex dilution and repeat testing, and the ability to preserve pediatric samples upon aspiration error. The Werfen NEO Iris system utilizes a proprietary dual-arm pipettor with advanced liquid level sensing and clog detection that is uniquely capable of meeting all these requirements simultaneously, ensuring sample integrity and minimizing the need for painful and time-consuming redraws from trainees.


Interoperability with Existing Systems: The analyzer must establish a bi-directional interface with the hospital's Electronic Health Record (EHR) and Laboratory Information System (LIS). The NEO Iris system has a proven and validated interface that is currently operational at other DoD facilities, ensuring seamless integration without extensive and risky custom development.


Response and Challenge:


Interested parties who believe they can meet the requirements are invited to submit a statement of capabilities and qualifications. This statement must be submitted in writing to the contact person identified in this notice and must be received no later than the noted time and date.


The statement of capabilities must include:


Company name, address, point of contact, telephone number, and email address.


A detailed description of your company's capabilities to provide the specified requirement.


Evidence that your company meets all the requirements outlined in the "Description of Requirement" section.


Any other information that demonstrates your ability to perform the work.


A determination by the Defense Health Agency HCD-S not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the HCD-S. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.


This notice of intent is not a request for competitive proposals.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 17 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS